HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway.

Abstract
Hepatic steatosis is highly correlated with insulin resistance and diabetes. Although, it has been demonstrated that activation of free fatty acid receptor 1 (FFAR1) by agonists showed benefits for the improvement of diabetes, the effects of FFAR1 agonists on hepatic steatosis were unknown. In this study, a high fat diet (HFD)-induced hepatic steatosis animal model was utilized to evaluate the effects of an FFAR1 agonist, GW9508, on hepatic lipid accumulation, and HepG2 hepatoma cells were also used to clarify the possible mechanisms. Administration of GW9508 significantly decreased the hepatic lipid accumulation with decreased expressions of lipogenesis-related proteins in HFD mice. Knockdown of hepatic Ffar1 by lentiviral vectors containing short hairpin RNA targeted to Ffar1 diminished the effect of GW9508 in HFD mice. In addition, GW9508 decreased oleic acid-induced lipid accumulation in HepG2 cells by decreases in the expression of lipogenesis-related proteins. Moreover, GW9508 downregulated the expression of sterol regulatory element-binding protein 1 (SREBP1) through a p38-dependent pathway, whereas knockdown of Ffar1 in HepG2 cells diminished the effect of GW9508 on the decrease in SREBP1. Considering all these results together, GW9508 exerts a therapeutic effect to improve hepatic steatosis through a p38-dependent pathway. Thus, investigation of chemicals that act on FFAR1 might be a new strategy for the treatment of hepatic steatosis.
AuthorsHorng-Yih Ou, Hung-Tsung Wu, Feng-Hwa Lu, Yu-Chu Su, Hao-Chang Hung, Jin-Shang Wu, Yi-Ching Yang, Chao-Liang Wu, Chih-Jen Chang
JournalJournal of molecular endocrinology (J Mol Endocrinol) Vol. 53 Issue 2 Pg. 165-74 (Oct 2014) ISSN: 1479-6813 [Electronic] England
PMID25008074 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 Society for Endocrinology.
Chemical References
  • Estrenes
  • FFAR1 protein, human
  • Pyrrolidinones
  • Receptors, G-Protein-Coupled
  • Sterol Regulatory Element Binding Protein 1
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Protein Kinase C
  • p38 Mitogen-Activated Protein Kinases
  • Phosphoinositide Phospholipase C
Topics
  • Animals
  • Cell Line
  • Diet, High-Fat (adverse effects)
  • Disease Models, Animal
  • Estrenes (administration & dosage, pharmacology)
  • Fatty Liver (drug therapy, etiology, metabolism, pathology)
  • Gene Knockdown Techniques
  • Hep G2 Cells
  • Humans
  • Lipid Metabolism (drug effects)
  • MAP Kinase Signaling System
  • Male
  • Mice
  • Phosphoinositide Phospholipase C (metabolism)
  • Protein Kinase C (metabolism)
  • Pyrrolidinones (administration & dosage, pharmacology)
  • RNA Interference
  • Receptors, G-Protein-Coupled (agonists, genetics, metabolism)
  • Sterol Regulatory Element Binding Protein 1 (genetics, metabolism)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: